🧠 Aevum Zenth Neuro Charter

The Neuro Charter

A universal framework for the ethical development, deployment, and governance of neurotechnology. Establishing the fundamental rights, responsibilities, and boundaries of neural interfaces.

12
Articles
47
Principles
3
Protocols
2025
Established
✓ Active v3.2
Last amended: December 15, 2025  |  Ratified by: 62 nations, 14 industry consortia
Preamble

Whereas the Mind Is the Last Frontier

We, the signatories of the Aevum Zenth Neuro Charter, recognize that the convergence of neuroscience, artificial intelligence, and bioengineering has ushered humanity into an era of unprecedented capability and corresponding peril. The ability to read, interpret, modulate, and augment neural activity — once confined to the realm of science fiction — now stands at the threshold of widespread deployment.

This Charter establishes a universal framework of rights, obligations, and technical standards governing all forms of neurotechnology, including but not limited to brain-computer interfaces (BCIs), neural implants, non-invasive brain imaging systems, cognitive augmentation devices, and any technology capable of interfacing with, recording, or altering human neural activity.

We affirm that the sanctity of human thought, the inviolability of consciousness, and the right to cognitive self-determination are fundamental human rights that must be preserved, protected, and enshrined in law, industry practice, and ethical frameworks across all jurisdictions and all applications of neurotechnology.

Sec. 0

Scope & Definitions

This Charter applies to all organizations, entities, and individuals engaged in the research, development, manufacturing, distribution, deployment, or operation of neurotechnology — whether within commercial enterprises, academic institutions, governmental agencies, or private ventures.

For purposes of this Charter, the following definitions shall apply:

View Full Definitions
  • Neurotechnology: Any device, software, system, or procedure designed to interface with, record from, stimulate, modulate, or otherwise interact with the biological neural tissue of a human or non-human primate.
  • Neural Data: Any information derived from neural activity, including but not limited to EEG signals, fMRI-derived data, spike trains, local field potentials, decoded cognitive states, emotional valence indicators, and reconstructed sensory experiences.
  • Cognitive Liberty: The right of every person to govern their own mental processes, including the right to access neurotechnology, the right to refuse such access, and the right to mental privacy free from unauthorized observation or modification.
  • Neural Interface Device (NID): Any hardware or software system that establishes a communication pathway between biological neural tissue and an external computing system, regardless of invasiveness, bandwidth, or latency.
  • Cognitive Enhancement: Any intervention using neurotechnology that exceeds baseline restoration of function, including enhancement of memory, attention, processing speed, emotional regulation, or sensory perception beyond species-typical ranges.
  • Neural Rights Holder: The natural person whose neural activity is being recorded, processed, or modulated, regardless of age, consent capacity, or jurisdiction.
Article I

Cognitive Liberty

Every person possesses the inalienable right to cognitive liberty — the absolute freedom to control one's own mental processes, to choose whether or not to engage with neurotechnology, and to refuse any form of neural interaction, monitoring, or modification without fear of retribution, discrimination, or legal penalty.

"No person shall be compelled to interface with neurotechnology. No employer, institution, government, or commercial entity may condition employment, education, healthcare access, civic participation, or essential services upon the adoption or use of neural interfaces."

This right extends across all contexts — employment, education, healthcare, military service, criminal justice, insurance underwriting, and any other domain where pressure to adopt neurotechnology might arise through economic coercion, institutional requirement, or social expectation.

View Enforcement Mechanisms
  • Prohibition of mandatory neurotechnology adoption in employment contracts or conditions of service
  • Legal standing for individuals to challenge institutional requirements for neural interfacing
  • Protection against insurance premium increases based on refusal to adopt monitoring neurotechnology
  • Right to disconnect: individuals may terminate neural data streams at any time without penalty
  • Whistleblower protections for employees reporting violations of cognitive liberty provisions
Article II

Neural Privacy

Neural data constitutes the most intimate category of personal information — encompassing thoughts, emotions, memories, intentions, and subconscious processes. Such data shall be afforded the highest possible level of legal and technical protection, exceeding standards applied to genetic, biometric, or financial information.

No entity may collect, store, process, transmit, analyze, or derive value from neural data without meeting all of the following conditions:

View Neural Privacy Requirements
  • Explicit, informed, and continuously revocable consent from the neural rights holder
  • End-to-end encryption of neural data using quantum-resistant cryptographic protocols
  • On-device processing where technically feasible, minimizing data transmission
  • Zero-knowledge proof architectures for verification without data exposure
  • Mandatory data minimization — collecting only neural signals strictly necessary for stated purpose
  • Automatic data purging upon termination of consent or expiration of retention period
  • Prohibition on inference of protected characteristics (political views, religious beliefs, sexual orientation) from neural data
  • Separate legal consent required for secondary uses beyond the original stated purpose
Article III

Informed Consent

Consent to neurotechnology interaction must be informed, voluntary, specific, and continuously revocable. Standard EULA-style consent mechanisms are explicitly insufficient for neural interfaces and shall not satisfy the requirements of this Article.

Valid informed consent requires a dedicated neuro-consent process that includes:

View Consent Process Requirements
  • Comprehensible disclosure of all known and potential risks, including long-term cognitive effects
  • Explanation of data flows, storage durations, and third-party sharing in non-technical language
  • Independent review period of no less than 72 hours before consent takes effect
  • Ability to granularly consent to specific data streams while withholding others
  • Mandatory periodic re-consent at intervals not exceeding 12 months
  • For minors: additional guardianship protocols with assent requirements scaling with developmental stage
  • Neuro-consent must be separable from any other terms of service or contractual agreement
  • Clear and accessible revocation mechanism available in real-time through the device interface
Article IV

Data Sovereignty

Every individual retains absolute sovereignty over their neural data. Neural data is not property that can be sold, licensed, or transferred — it is an extension of personhood. No entity may claim ownership, copyright, or proprietary rights over raw neural data or its direct derivatives.

Organizations processing neural data serve exclusively as stewards and processors under explicit authorization. All neural data shall remain legally and ethically bound to the originating person throughout its lifecycle.

Article V

Identity Integrity

The integrity of personal identity — the continuity of selfhood, authentic memory, and unmanipulated personality — shall be protected against unauthorized modification through neurotechnology. No entity may alter, suppress, or enhance cognitive functions that fundamentally affect identity formation or self-perception without meeting the highest threshold of consent and oversight.

"The right to be oneself, unmodified by external technological intervention, is fundamental. Any neurotechnology that alters personality, memory, values, or emotional baselines requires Level-5 Oversight certification and independent judicial review."

Article VI

Access & Equity

Neurotechnology must not deepen existing social, economic, or geographic inequalities. Organizations deploying neurotechnology bear affirmative responsibility to ensure equitable access and prevent the creation of cognitive divides between those who can and cannot afford neural augmentation or therapeutic interfaces.

This Article mandates:

View Equity Requirements
  • Minimum 15% of therapeutic neurotechnology production reserved for subsidized access programs
  • Prohibition on neurotechnology pricing models that create access based on neural data value extraction
  • Mandatory open-source publication of non-proprietary neural decoding algorithms for therapeutic applications
  • Anti-discrimination protections against "neuro-divide" disparities in education and employment
  • Requirements for geographic distribution equity across all signatory nations
Article VII

Safety Standards

All neurotechnology must satisfy rigorous, independently verified safety standards before deployment. The Aevum Zenth Safety Classification Framework establishes five tiers of risk assessment and corresponding regulatory requirements:

View Safety Classification Framework
  • Level 1 — Passive Monitoring: Non-invasive, read-only neural signal acquisition. Requires basic certification and annual safety audit.
  • Level 2 — Non-Invasive Modulation: TMS, tDCS, and similar non-invasive stimulation. Requires Level-2 certification and quarterly audit.
  • Level 3 — Minimally Invasive: Implantable electrodes below the blood-brain barrier. Requires Level-3 certification, FDA/EMA equivalent approval, and monthly audit.
  • Level 4 — Deep-Brain Integration: Systems with bidirectional data flow and closed-loop modulation. Requires Level-4 certification and real-time monitoring dashboards.
  • Level 5 — Identity-Affecting: Technologies altering personality, memory, or fundamental cognition. Requires Level-5 certification, independent judicial review per deployment, and permanent audit trails.
Article VIII

Accountability

Organizational accountability for neurotechnology deployment shall be strict and non-delegable. The deploying entity retains ultimate responsibility for all outcomes, whether caused by hardware failure, software error, algorithmic bias, operator negligence, or unforeseen neurobiological reactions.

The "moving target" defense — claiming that machine learning models evolved beyond the scope of original testing — is explicitly rejected under this Charter.

Article IX

Oversight Bodies

The Aevum Zenth Neuro Oversight Commission (AZ-NOC) is established as an independent body with authority to certify, audit, investigate, and sanction neurotechnology deployments across all signatory organizations and jurisdictions.

The Commission comprises 12 independent members drawn from neuroscience, law, ethics, engineering, patient advocacy, and civil liberties — no member may have financial ties to any neurotechnology enterprise.

Article X

Enforcement

Violations of this Charter carry graded sanctions proportional to severity, including mandatory system shutdowns, financial penalties not to exceed 8% of global annual revenue, individual professional disqualifications, and criminal referral for willful violations involving harm to neural rights holders.

Article XI

Global Cooperation

Neurotechnology transcends borders. This Charter requires multilateral coordination among signatory nations and organizations to prevent regulatory arbitrage, ensure consistent enforcement, and establish mutual recognition of certification standards.

Article XII

Amendments

This Charter is a living document. Amendments may be proposed by the Oversight Commission, by any three signatory nations in concert, or by petition of 10,000 verified neural rights holders. Amendments require a two-thirds supermajority vote of the Commission and 90-day public comment period before ratification.

🏛 Ratified By

🧠
Dr. Elena Voss
Chair, AZ-NOC Oversight Commission
⚖️
Kofi Mensah Jr.
Director, Global Neuro Rights Council
🔬
Dr. Yuki Tanaka
Lead, Zenth Advanced Research — Neural Systems
🌍
Amb. Sarah Okafor
UN Special Envoy, Emerging Technology Ethics
🛡️
Prof. Marcus Chen
Director, Neuro Safety Certification Board
Aevum Zenth Conglomerate
Corporate Charter Authority
📜

Have Questions?

Our Neuro Ethics team is available for consultations, compliance reviews, and questions about the Charter's provisions.

Request Consultation → Read FAQ
}